Nestmedic P/CF

Mitä Nestmedic tekee? Nestmedic SA generates revenue through the sale of its Pregnabit telemedicine CTG device, which includes the display device, fetal heart rate probe, wrist heart rate monitor, tocodynamometer probe, and fetal movement marker. The company targets healthcare providers and clinics that require home-based fetal monitoring solutions, enabling pregnant women to conduct CTG tests independently. Medical Telemonitoring Center (MTC) processes the wireless data from Pregnabit, providing medical analysis and opinions to users. Nestmedic SA's product is designed for direct consumer use in home settings with professional medical oversight. The Pregnabit solution is marketed to healthcare institutions seeking to offer remote fetal health monitoring services. By eliminating the need for in-person specialist visits, the device supports cost-effective maternal care. MTC serves as the central hub for data analysis, ensuring medical professionals can interpret results and deliver timely advice without direct patient interaction. Nestmedic SA focuses on the development and production of this integrated telemedicine system for fetal monitoring. Nestmedic SA's business model relies on selling the Pregnabit device and associated hardware to healthcare facilities. The wireless transmission of data to MTC allows for continuous medical supervision without requiring patients to visit clinics. The company's core offering combines hardware, software, and medical analysis services to provide a comprehensive solution for home-based fetal health monitoring. Nestmedic on yksi Eurpooliin suosituimmista yhtiöistä.